The WACC of Clearbridge Health Ltd (1H3.SI) is 5.4%.
Range | Selected | |
Cost of equity | 4.5% - 6.0% | 5.25% |
Tax rate | 1.9% - 2.2% | 2.05% |
Cost of debt | 4.6% - 7.0% | 5.8% |
WACC | 4.5% - 6.3% | 5.4% |
Category | Low | High |
Long-term bond rate | 2.7% | 3.2% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.34 | 0.37 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 4.5% | 6.0% |
Tax rate | 1.9% | 2.2% |
Debt/Equity ratio | 0.63 | 0.63 |
Cost of debt | 4.6% | 7.0% |
After-tax WACC | 4.5% | 6.3% |
Selected WACC | 5.4% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
1H3.SI | Clearbridge Health Ltd | 0.63 | -0.48 | -0.3 |
1419.HK | Human Health Holdings Ltd | 0.48 | 0.06 | 0.04 |
1B1.SI | HC Surgical Specialists Ltd | 0.13 | 0.06 | 0.05 |
1J3.SI | Asian Healthcare Specialists Ltd | 0.06 | -0.01 | -0.01 |
505.SI | AsiaMedic Ltd | 1.44 | 0.06 | 0.02 |
516110.BO | Scandent Imaging Ltd | 0.14 | -0.55 | -0.48 |
5NG.SI | Healthway Medical Corporation Ltd | 0.1 | -0.64 | -0.58 |
MIJ.SI | Alliance Healthcare Group Ltd | 0.87 | 0.24 | 0.13 |
P8A.SI | Cordlife Group Ltd | 0.03 | 0.03 | 0.03 |
SMILE.KL | Smile-Link Healthcare Global Bhd | 0.35 | 0.3 | 0.22 |
Low | High | |
Unlevered beta | 0.01 | 0.04 |
Relevered beta | 0.01 | 0.06 |
Adjusted relevered beta | 0.34 | 0.37 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 1H3.SI:
cost_of_equity (5.25%) = risk_free_rate (2.95%) + equity_risk_premium (5.60%) * adjusted_beta (0.34) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.